Elipovimab, CAS 2101210-43-7

Product Description: Elipovimab is a potent broadly neutralizing HIV-1 antibody for the targeted elimination of HIV-infected cells[1]

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Caroline Thue Hvilsom, et al. TLR-Agonist Mediated Enhancement of Antibody-Dependent Effector Functions as Strategy For an HIV-1 Cure. Front Immunol. 2021 Sep 23;12:704617.

CAS Number: 2101210-43-7

Molecular Weight: N/A

Compound Purity: 97.64

Research Area: Infection

Solubility: 10 mM in DMSO

Target: HIV

• Artikelnummer: MEXHY-P99937-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99937-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated